CLASS II Device recall · Reported 11 Nov 2020 · FDA Enforcement Report

Novaplus Monitoriing Electrode with Foam Tape and Sticky Gel recalled

3M Company - Health Care Business is recalling Novaplus Monitoriing Electrode with Foam Tape and Sticky Gel, distributed nationwide in the US. The recall was initiated on 15 Sep 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCat. No. V2560-3 (SKU: 70-2011-8380-6, SAP #: 7100205820). GTIN: 10707387788169 (pouch); 50707387788167 (shipper) Lots: 202201EB (Expiration 2022-01-01)
Quantity recalled156,600 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0420-2021
FDA event ID
86519
Recalling firm
3M Company - Health Care Business, Saint Paul, MN
Classification
Class II
Status
Terminated
Recall initiated
15 Sep 2020
FDA classified
5 Nov 2020
Reported
11 Nov 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

15 Sep 2020Recall initiated by company
5 Nov 2020Classified by FDA+51 days
11 Nov 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Corrosion could cause performance failures in the product.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Novaplus Monitoriing Electrode with Foam Tape and Sticky Gel - Product Usage: intended to be used by healthcare professionals for ECG monitoring. 3 electrodes per card; 1 card per pouch; 200 pouches per shipper box (600 electrodes total).

Where it was distributed

Worldwide distribution - US Nationwide distribution and the countries of Europe (Austria, Belgium, Switzerland, Germany, Spain, Finland, France, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Sweden) and Worldwide (China, Taiwan, Singapore, Indonesia, Japan, Mexico, Peru, Costa Rica, Canada).

Nationwide

Questions about this recall

Why was it recalled?

Corrosion could cause performance failures in the product.

Which lots are affected?

Cat. No. V2560-3 (SKU: 70-2011-8380-6, SAP #: 7100205820). GTIN: 10707387788169 (pouch); 50707387788167 (shipper) Lots: 202201EB (Expiration 2022-01-01)

Where was it sold?

Worldwide distribution - US Nationwide distribution and the countries of Europe (Austria, Belgium, Switzerland, Germany, Spain, Finland, France, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Sweden) and Worldwide (China, Taiwan, Singapore, Indonesia, Japan, Mexico, Peru, Costa Rica, Canada).

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

4 other products · FDA event 86519

This product is part of a recall event; the main page for the event is 3M Red Dot Monitoring Electrode with Foam Tape recalled.

More recalls from 3M Company - Health Care Business

All 40

Other Hip & Knee Implants recalls

All 3,111